JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated November 3, 2023 (including amendments thereto) with respect to the Common Shares, no par value, of Repare Therapeutics Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: November 3, 2023
BIOTECHNOLOGY VALUE FUND, L.P. | BIOTECHNOLOGY VALUE TRADING FUND OS LP | |||
By: | BVF I GP LLC, its general partner | By: | BVF Partners L.P., its investment manager | |
By: | BVF Inc., its general partner | |||
By: |
/s/ Xxxx X. Xxxxxxx |
|||
Xxxx X. Xxxxxxx | By: | /s/ Xxxx X. Xxxxxxx | ||
Chief Executive Officer | Xxxx X. Xxxxxxx | |||
President | ||||
BVF I GP LLC | ||||
BVF GP HOLDINGS LLC | ||||
By: | /s/ Xxxx X. Xxxxxxx | |||
Xxxx X. Xxxxxxx | By: | /s/ Xxxx X. Xxxxxxx | ||
Chief Executive Officer | Xxxx X. Xxxxxxx | |||
Chief Executive Officer | ||||
BIOTECHNOLOGY VALUE FUND II, L.P. | ||||
BVF PARTNERS L.P. | ||||
By: | BVF II GP LLC, its general partner | |||
By: | BVF Inc., its general partner | |||
By: |
/s/ Xxxx X. Xxxxxxx |
|||
Xxxx X. Xxxxxxx | By: | /s/ Xxxx X. Xxxxxxx | ||
Chief Executive Officer | Xxxx X. Xxxxxxx | |||
President | ||||
BVF II GP LLC | ||||
BVF INC. | ||||
By: | /s/ Xxxx X. Xxxxxxx | |||
Xxxx X. Xxxxxxx | By: | /s/ Xxxx X. Xxxxxxx | ||
Chief Executive Officer | Xxxx X. Xxxxxxx | |||
President | ||||
BVF PARTNERS OS LTD. | ||||
/s/ Xxxx X. Xxxxxxx | ||||
By: | BVF Partners L.P., its sole member | XXXX X. XXXXXXX | ||
By: | BVF Inc., its general partner | |||
By: |
/s/ Xxxx X. Xxxxxxx |
|||
Xxxx X. Xxxxxxx | ||||
President |